key: cord-0856016-vwra6r5b authors: Munitz, A.; Yechezkel, M.; Dickstein, Y.; Yamin, D.; Gerlic, M. title: The rise of SARS-CoV-2 variant B.1.1.7 in Israel intensifies the role of surveillance and vaccination in elderly date: 2021-02-19 journal: nan DOI: 10.1101/2021.02.16.21251819 sha: 83d3ed67182ec34269b61a113e0d864c75d2bc6c doc_id: 856016 cord_uid: vwra6r5b Since the emergence of the SARS-CoV-2 pandemic various generic variants have been described. Of specific interest is a new variant, which was observed in England during December 2020 and is now termed B.1.1.7. This variant is now associated with increased infectivity and therefore its spread within the community is of great importance. The Israeli government established three noteworthy programs namely, mass PCR testing, focused protection of the elderly and more recently an unparalleled prioritized vaccination program. In this study we analyzed primary data of >300,000 RT-PCR samples collected throughout December 6th 2020 until February 10th 2021 in the general community and nursing homes. We identified that within a period of six weeks, the B.1.1.7 variant was capable of out competing the wildtype SARS-CoV-2 strain to become the main strain. Furthermore, we show that the transmission of B.1.1.7 in the 60+ population reached a near complete halt, due to an ongoing surveillance testing program in nursing homes and the vaccination program of Israel. Thus, proactive protection programs such as routine surveillance and monitoring of populations at risk combined with prioritized vaccination, is achievable and will result in a reduction of severe illness and subsequent death. In December 2020, a distinct phylogenetically cluster of SARS-CoV-2 was identified in London as well as in Southeast and East of England 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 19, 2021. ; https://doi.org/10.1101/2021.02. 16 .21251819 doi: medRxiv preprint 3 human epithelial cells 3 . At least two mutations were suggested to have biological significance. Mutation N501Y has been shown to enhance binding affinity to human angiotensin converting enzyme 2 (ACE2) 3 , while mutation P681H, was suggested to affect infection and transmission due to its location 4, 5 . In support of this, preliminary evidence from epidemiological studies estimated that B.1.1.7 is 43-82% more transmissible 6 and thus associated with an increase in the effective reproduction number by a factor of 1.4-1.8 7 . During the COVID-19 pandemic, Israel has established three noteworthy programs. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint To evaluate the daily % , we used the methodology previously introduced by Cori et al. 10, 11 that was also considered in our previous work 12, 13 . This data-driven approach suggests that % is the ratio between % , the number of new infections generated at day t and ∑ %() *+, %(* * , the sum of infection incidence up to time step t − 1 weighted by the infectivity function * . For * , we considered 10 days truncated gamma distribution with a mean of 3.96 days (95% CI: 3.53-4.39 days), an SD 4.75 days (4.46-5.07 days) 14 . We used our data to evaluate the reproductive number for both the SARS-COV-2 wild type and the B. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Figure 1B, December 30, 2021) . Furthermore, we found that during the entire period the variant was 45% more transmissive then the wildtype. Figure 1C ). In support of this, pearson correlation analysis of the rise in incidence among the different age groups revealed that between December 24, 2020 and January 14, 2021 the rise in the incidence of B.1.1.7 was highly correlated among all age groups (r>0.99, Figure 1C ). Following January 14, 2021, a striking decline was observed in the correlation coefficient only in the 60+ age group (r= -0.35 and -0.28, 60+ vs. 0-19 or 20-59 age, respectively, Figure 1C ). Notably, this phenomenon was associated with the fact that by that time point, 50% of the 60+ aged population was two weeks post the 1 st dose of vaccination. To assess the ongoing surveillance testing program in nursing homes, we compared is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 19, 2021. ; https://doi.org/10.1101/2021.02.16.21251819 doi: medRxiv preprint homes with matching age groups (t-test, p<0.001) ( Figure 1D ). Collectively, as viral load drives transmission 15, 16 these data underscores the important role of random surveillance testing in nursing homes. Using data collected through RT-PCR testing at the Electra-TAU lab we investigated the dynamics and spread of the B.1.1.7 variant. We identified that within a period of six weeks, the B.1.1.7 variant was capable of out competing the wildtype SARS-CoV-2 strain to become the main strain (more than 90% of positive tests). We found that the B.1.1.7 variant is 45% more transmissible than the wildtype strain (95% CI: 20-60%). This is within the range of previous estimates, which suggested a 1.56 increase in England 9 . These similar estimates were observed despite the substantial differences between the countries in terms of demographic characteristics including age distribution, household size, the density of living areas, as well as key settings that impact transmission including lockdowns and vaccination coverage. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Our data confirmed that pro-active surveillance programs of populations at risk such as those found in nursing homes were capable of early detection, which likely enabled containment of further viral spread within this housing community. This is observed by the significant difference in Ct threshold levels, which were higher in nursing homes in comparison with the general population. Thus, proactive protection programs such as routine surveillance and monitoring of populations at risk combined with prioritized vaccination, is achievable and will result in a reduction of severe illness and subsequent death. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint This study was approved by the Tel Aviv University Institutional review board (IRB# 0002746-2). The authors declare that they have no competing interests. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 19, 2021. ; https://doi.org/10.1101/2021.02.16.21251819 doi: medRxiv preprint above 60 years at nursing homes versus infected individuals above 60 years at the general community. Data were calculated using GraphPad Prism 9; the black dotted line represents the calculated median and quartiles values. Statistical analysis was performed using a t-test, P values are shown. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 19, 2021. ; https://doi.org/10.1101/2021.02.16.21251819 doi: medRxiv preprint New variant of SARS-CoV-2 in UK causes surge of COVID-19 Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern Transmission of SARS-CoV 1.1.7 in England: Insights from linking epideemiological and genetic data Israel's rapid rollout of vaccinations for COVID-19 Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England A new framework and software to estimate time-varying reproduction numbers during epidemics Practical considerations for measuring the effective reproductive number Effect of ebola progression on transmission and control in liberia Vaccination strategies against respiratory syncytial virus The serial interval of COVID-19 from publicly reported confirmed cases Temporal dynamics in viral shedding and transmissibility of COVID-19 Transmission of COVID-19 in 282 clusters in Catalonia New variant of SARS-CoV-2 in UK causes surge of COVID-19 Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern Transmission of SARS-CoV 1.1.7 in England: Insights from linking epideemiological and genetic data Israel's rapid rollout of vaccinations for is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England A new framework and software to estimate time-varying reproduction numbers during epidemics Practical considerations for measuring the effective reproductive number Effect of ebola progression on transmission and control in liberia Vaccination strategies against respiratory syncytial virus The serial interval of COVID-19 from publicly reported confirmed cases Temporal dynamics in viral shedding and transmissibility of COVID-19 Transmission of COVID-19 in 282 clusters in Catalonia It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint